GH Research GHRS
NASDAQ GHRS
$28.05 +0.13 (+0.47%)
As of: Sep 4, 2026 · 3:21 PM EDT

GH Research (GHRS) Sales of Property, Plant and Equipment (2024 - 2025)

Analysis

GH Research (GHRS) Sales of Property, Plant and Equipment (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 GH Research 1.71 Bn 1.35 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 12.59 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 13.00 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 5.00 Mn